- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02592005
Impact of Particulate Matter on Mothers and Babies in Antwerp (IPANEMA) (IPANEMA)
Impact of Particulate Matter on Mothers and Babies in Antwerp (IPANEMA), a Prospective Cohort Study on the Impact of Pollutants and Particulate Matter in Pregnancy: Methodology and Design
Introduction: An emerging body of evidence indicates that there is an association between air pollution exposure in pregnancy and adverse pregnancy outcomes (Rudra, Williams, Sheppard , Koenig, & Schiff, 2011; Dadvand, et al., 2013; Ritz, et al., 2014). Adverse pregnancy outcomes tend to lead to adverse neonatal outcome and a higher economic cost. Epidemiologic studies have also revealed that cardiovascular complications during pregnancy, such als preeclampsia, are associated with a greater cardiovascular risk during later life ( Abramson & Melvin, 2014).
Aim: This study wants to examine the effects of exposure to environmental factors, polluents and particulate matter on the clinical pregnancy outcome for mother and child and to determine which biochemical changes in maternal, placental and cord blood best explain this effect.
Methods: This study will be performed in a prospective cohort setup (n=200), recruited from the prenatal clinic in the University Hospital Antwerp. The data collection consists of four questionnaires (intake, both urine samples and postpartum), two blood samples (28 weeks and post-partum), two urine samples (20 and 30 weeks), two hair samples (20 weeks and post-partum), cord blood and the placenta.
Results and conclusion: As the study will start in November 2014, no results are available yet.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Blood collections (maternal and umbilical cord) Venous blood is drawn around 24 weeks of gestational age.
Table 1 Tests on maternal blood sample:Routine blood sampling (UZA) Urea, Creatinin, CRP, LDH, AST, ALT, Uric acid, APTT, PT, Fibrinogen, D-dimers, Glucose, Erythrocytes/hematocrit, Hemoglobin, Thrombocytes, Leukocytes, Ferritin, Toxoplasmosis (IgG & IgM), CMV (IgG & IgM), Herpes simplex IgG, Varicella zoster IgG, Rubella IgG, Parvovirus (IgG & IgM), Syphilis (RPR & TPHAM), Indirect Coombs AML sFlt-1, PlGF, Cystatin C VITO m(i)RNA expression, telomere length, DNA methylation
Umbilical cord blood is taken at time of birth. Table 2 Tests on umbilical blood sample VITO m(i)RNA expression, telomere length, DNA methylation
Urine collections Urine samples are taken by the pregnant women themselves, after a minimum of 8 hours fasting (morning urine). Samples are handed to the midwife at the antenatal visit, and placed at -20°C freezer within 12 hours of collection. Analysis will be performed at the Flemish Institute for Technological Research (VITO).
Two urine samples are collected: at 20 weeks and at 30 weeks gestational age. 8 oxo deoxyguanosine will be determined in the samples.
Hair collections Hair samples are drawn by the midwife around 24 weeks of gestational age and three days after delivery. Long periods of stress are associated with increased hair cortisol concentrations (Stalder & Kirschbaum, 2012). Confounding variables are low maternal education, season of delivery, smoking during pregnancy and obesity (Braig, et al., 2015).Titanium scissors are cleaned with denaturated ethanol and the midwife wears disposable gloves in order to limit contamination. A lock of hair with a thickness of a match (2 mm) and a length of 4 cm will be taken and put in an envelope. Analysis will be performed at the University of Southern Denmark.
Collection of particulate matter on bedroom window Participants will be asked to clean their bedroom window with clear water on the in- and outside around 24 weeks of gestation. A poster (A4 format) will then be attached to the window to create a standardized area for the measurement of magnetic particles. After minimal 4 weeks, the area in the poster is cleaned with a sterile pre-injection swab, on both sides of the window. Swabs are transported in a plastic bag and the ferro(i)magnetic particulate matter fraction will be quantified by Saturated Isothermal Remanent Magnetization.
Questionnaires
There are four different questionnaires:
Questionnaire on general habits, socio-economic factors, lifestyle and eating habits A self-designed questionnaire is used to extensively collect information on ethnic origin and and education level, on employment, income and work environment, on family history of diseases and chronic disorders, on eating habits, on previous pregnancies and other habits (smoking, alcohol consumption).
Questionnaire on lifestyle during previous 3 days A self-designed questionnaire is used to extensively collect information on contact with possible toxic factors and on eating pattern of the previous 3 days.
Questionnaire on residential facts A self-designed questionnaire is used to collect information about the exact location of the bedroom window and other possible factors influencing concentrations of particulate matter.
Questionnaire on stress factors and birth facts A self-designed questionnaire is used to extensively collect information on stress levels during pregnancy, on birth facts and on medication during pregnancy.
Questionnaires will be taken at different visits:< 12 weeks 20 weeks 30 weeks birth Questionnaire on general habits, socio-economic factors, lifestyle and eating habits Recruitment Questionnaire on lifestyle during previous 3 days Urine sample 1 Urine sample 2 Questionnaire on residential facts 4-8 weeks prior to visit Questionnaire on stress factors and birth facts 3 days after birth
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Antwerp
-
Edegem, Antwerp, Belgium, 2650
- Recruiting
- University Hospital Antwerp
-
Contact:
- Lena EM Van den Eeden, MD
- Phone Number: +3214564450
- Email: leen.vandeneeden@thomasmore.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- A singleton pregnancy from 12 weeks of gestational age
- Delivery planned in a hospital within the network of the Antwerp University
- Dutch speaking
Exclusion Criteria:
- Multiple pregnancy
- Planned home delivery of in another hospital
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
preeclampsia
Time Frame: From date of randomization until the date of delivery
|
From date of randomization until the date of delivery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
birth weight
Time Frame: at delivery, assessed up to 40 weeks
|
at delivery, assessed up to 40 weeks
|
|
preterm birth
Time Frame: at delivery, assessed up to 40 weeks
|
at delivery, assessed up to 40 weeks
|
|
gestational diabetes
Time Frame: From date of randomization until the date of delivery
|
From date of randomization until the date of delivery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: yves jacquemyn, PhD, Universiteit Antwerpen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14/40/411
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Turku University HospitalUniversity of TurkuCompleted
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
Clinical Trials on amount of fine dust and other environmental exposure
-
Centre Hospitalier Universitaire de NiceCompletedMuscular DystrophiesFrance
-
Zhejiang Provincial People's HospitalWithdrawnMetastatic Colorectal Cancer | Colorectal Cancer | Thymalfasin
-
Washington University School of MedicinePennington Biomedical Research CenterCompletedHypercholesterolemia | Coronary Heart DiseaseUnited States
-
University of Southern DenmarkOdense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsCompletedAutoimmune Diseases | Inflammatory Bowel Diseases | Uveitis | Psoriasis | Spondylarthropathies | Crohn Disease (CD) | Arthritis, Rheumatoid (RA) | Arthritis, Psoriatic (PsA) | Hidradenitis Suppurativa (HS) | Colitis, Ulcerative (UC)Denmark
-
Centre Hospitalier Universitaire, AmiensActive, not recruitingPreterm Infant | Exposure to RadiofrequencyFrance
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | CardiotoxicityUnited States
-
Meir Medical CenterCompletedOvarian StimulationIsrael
-
CorEvitasRecruiting
-
Lucie HeinzerlingRecruitingImmune-related Adverse EventGermany